Tag

CAFC

Drug Developers’ Statements Not Available as Evidence of Obviousness

The U.S. Court of Appeals for the Federal Circuit (CAFC) in Eli Lilly & Co. v. Teva Pharmaceuticals USA, Inc.(Fed. Cir. 2010) affirmed a permanent...

Categories

Archive

MWZB Newsletter Signup

Subscribe